Risk of pneumonia in patients taking statins: Population-based nested case-control study

British Journal of General Practice

Volumn 61, Issue 592, 2011, Pages

  Vinogradova, Yana ^a   Coupland, Carol ^a   Hippisley Cox, Julia ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

General practice; Pneumonia; Population; Statins

Indexed keywords

ANTACID AGENT; ATORVASTATIN; CERIVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DRUG USE; FEMALE; GENERAL PRACTICE; GROUPS BY AGE; HUMAN; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; LOBAR PNEUMONIA; MALE; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRESCRIPTION; RISK FACTOR; SEX DIFFERENCE; STREPTOCOCCUS PNEUMONIA;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; COMORBIDITY; GREAT BRITAIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOGISTIC MODELS; MIDDLE AGED; PNEUMONIA; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 83355174130     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp11X606654     Document Type: Article

References (33)

1. Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax 2009; 64(Suppl 3): iii 1-55.
2. O'Meara ES, White M, Siscovick DS, et al. Hospitalization for pneumonia in the Cardiovascular Health Study: incidence, mortality, and influence on longer-term survival. J Am Geriatr Soc 2005; 53(7): 1108-1116. (Pubitemid 41632509)
3. Lim WS, Lewis S, Macfarlane JT. Severity prediction rules in community acquired pneumonia: a validation study. Thorax 2000; 55(3): 219-223. (Pubitemid 30245972)
4. Myles PR, McKeever TM, Pogson Z, et al. The incidence of pneumonia using data froma computerized general practice database. Epidemiol Infect 2009; 137(5): 709-716.
5. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA 2002; 288(4): 455-461. (Pubitemid 34787476)
6. National Institute for Health and Clinical Excellence. Statins for the prevention of cardiovascular events in patients at increased risk of developing cardiovascular disease or those with established cardiovascular disease guidance type. Technology Appraisal 094. London: NICE, 2006.
7. Hippisley-Cox J, Coupland C. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. BMJ 2010; 340: c2197.
8. Terblanche M, Almog Y, Rosenson RS, et al. Statins and sepsis: multiple modifications at multiple levels. Lancet Infect Dis 2007; 7(5): 358-368. (Pubitemid 46590065)
9. Dechend R, Gieffers J, Dietz R, et al. Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation. Circulation 2003; 108(3): 261-265. (Pubitemid 36899013)
10. Stalker TJ, Lefer AM, Scalia R. A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid. Br J Pharmacol 2001; 133(3): 406-412. (Pubitemid 33027777)
11. Montecucco F, Mach F. Update on statin-mediated anti-inflammatory activities in atherosclerosis. Semin Immunopathol 2009; 31(1): 127-142.
12. Merx MW, Liehn EA, Graf J, et al. Statin treatment after onset of sepsis in a murine model improves survival. Circulation 2005; 112(1): 117-124. (Pubitemid 40962577)
13. Jerwood S, Cohen J. Unexpected antimicrobial effect of statins. J Antimicrob Chemother 2008; 61(12): 362-364.
14. Almog Y, Shefer A, Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004; 110(7): 880-885. (Pubitemid 39096018)
15. Thomsen RW, Riis A, Kornum JB, et al. Preadmission use of statins and outcomes after hospitalization with pneumonia: population-based cohort study of 29 900 patients. Arch Intern Med 2008; 168(19): 2081-2087.
16. Chalmers JD, Singanayagam A, Murray MP, Hill AT. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 2008; 121(11): 1002-1007. e1.
17. Mortensen E, Restrepo M, Anzueto A, Pugh J. The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia. Respir Res 2005; 6(1): 82.
18. Majumdar SR, McAlister FA, Eurich DT, et al. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006; 333(7576): 999.
19. Schlienger RG, Fedson DS, Jick SS, et al. Statins and the risk of pneumonia: a population-based, nested case-control study. Pharmacotherapy 2007; 27(3): 325-332. (Pubitemid 46327900)
20. van de Garde EMW, Hak E, Souverein PC, et al. Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax 2006; 61(11): 957-961. (Pubitemid 44787165)
21. Myles PR, Hubbard RB, McKeever TM, et al. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study. Pharmacoepidemiol Drug Saf 2009; 18(4): 269-275.
22. Dublin S, Jackson ML, Nelson JC, et al. Statin use and risk of community acquired pneumonia in older people: population based case-control study. BMJ 2009; 338: b2137.
23. Vinogradova Y, Hippisley-Cox J, Coupland C. Identification of new risk factors for pneumonia: population based case control study. Br J Gen Pract 2009; 59(567): 742-749.
24. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Performance of the QRISK cardiovascular risk prediction algorithmin an independent UK sample of patients from general practice: a validation study. Heart 2008; 94(1): 34-39.
25. Gulmez SE, Holm A, Frederiksen H, et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med 2007; 167(9): 950-955. (Pubitemid 46762758)
26. Laheij RJF, Sturkenboom MCJM, Hassing R-J, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004; 292(16): 1955-1960. (Pubitemid 39411203)
27. Vila-Corcoles A, Salsench E, Rodriguez-Blanco T, et al. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study. Vaccine 2009; 27(10): 1504-1510.
28. Myles PR, Hubbard RB, McKeever TM, et al. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study. Pharmacoepidemiol Drug Saf 2009;18(4): 269-75.
29. Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69(1): 4-14.
30. Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract 2010; 60(572): e128-e136.
31. Ashworth M, Lloyd D, Smith RS, et al. Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner 'Quality and Outcomes Framework'. J Public Health 2007; 29(1): 40-47.
32. Filion KB, Delaney JAC, Brophy JM, et al. The impact of over-the-counter simvastatin on the number of statin prescriptions in the United Kingdom: a view from the General Practice Research Database. Pharmacoepidemiol Drug Saf 2007; 16(1): 1-4. (Pubitemid 46164969)
33. Glynn RJ, Schneeweiss S, Wang PS, et al. Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol 2006; 59(8): 819-828. (Pubitemid 44040877)